They are a clinical stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation
Last Closing Price
October 13, 2017
Credit Suisse, Jefferies, Stifel
To view the prospectus for AnaptysBio, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253